【摘要】 目的:分析醒脑静联合脑苷肌肽治疗对重症颅脑损伤患者NIHSS评分及生存质量的影响。方法:选取本院于2018年8月至2019年12月期间收治的135例重症颅脑损伤患者为研究对象,按照随机数字表法将其分为研究组和参照组,研究组患者68例,参照组患者67例,参照组采用常规治疗与脑苷肌肽治疗,研究组采用常规治疗与醒脑静联合脑苷肌肽治疗,对比两组患者治疗后NIHSS评分及生存质量。结果:研究组患者治疗1个疗程、2个疗程、1个月后的NIHSS评分均低于参照组(P<0.05);研究组患者治疗1个疗程、2个疗程、1个月后的生存质量评分高于参照组(P<0.05)。结论:醒脑静联合脑苷肌肽治疗对重症颅脑损伤患者可明显减轻患者神经功能损害,同时提高患者生存质量。更多还原

【Abstract】 Objective:To analyze the effect of Xingnaojing combined with camp on NIHSS score and quality of life in patients with severe brain injury. Methods: 135 patients with severe craniocerebral injury admitted in our hospital from August 2018 to December 2019 were selected as the study objects. According to the method of random number table, they were divided into study group and reference group, 68 patients in study group and 67 patients in reference group. The reference group was treated with routine treatment and camp, while the study group was treated with routine treatment and Xingnaojing combined camp, and the two groups were compared NIHSS score and quality of life after treatment. Results: The NIHSS score of the study group was lower than that of the reference group(P<0.05) after one course, two courses and one month of treatment, and the QOL score of the study group was higher than that of the reference group(P<0.05) after one course, two courses and one month of treatment. Conclusion: Xingnaojing combined with cerebroside and carnosine can significantly reduce the neurological damage of patients with severe brain injury, and improve the quality of life of patients.更多还原